Literature DB >> 7562351

Dose-dependent gingival overgrowth induced by cyclosporin in rats.

E Fu1, S Nieh, H L Chang, S L Wang.   

Abstract

This study evaluated the effect of dosage on severity of cyclosporin-A (CSA) induced gingival overgrowth. Eighty (80) male Sprague-Dawley rats were randomly distributed into 4 groups. Rats in each group daily received CSA in mineral oil by gastric feeding at dosages of 0 (control), 3, 10, and 30 mg/kg, respectively, for 6 weeks. Stone models of the mandibular incisal region were obtained biweekly and were used for analysis of the gingival dimensions. Animals were sacrificed at the end of week 6 and tissue sections were processed for histopathologic evaluations. Animals were sacrificed at the end of week 6 and tissue sections were processed for histopathologic evaluation Gingival overgrowth including bucco-lingual and mesio-distal width and vertical height were significantly increased with increasing CSA dosage. Furthermore, the gingival dimensions displayed a positive linear relation to dosage and treatment duration. The histopathologic evaluation revealed a granulomatous tissue wedging the tooth-gingival interface in the 3 mg/kg group. This tissue had reached exuberant size in the 10 and 30 mg/kg groups. In summary, the analysis of gingival dimensions the histopathologic evaluation shows a dose-dependent effect on the severity of CSA-induced gingival overgrowth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562351     DOI: 10.1902/jop.1995.66.7.594

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  2 in total

1.  Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice.

Authors:  Mohammad A Assaggaf; Alpdogan Kantarci; Siddika S Sume; Philip C Trackman
Journal:  Am J Pathol       Date:  2015-04-02       Impact factor: 4.307

2.  Local inflammation exacerbates cyclosporine a-induced gingival overgrowth in rats.

Authors:  Jianbin Guo; Wenyu Wang; Liyan Yao; Fuhua Yan
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.